MYBPH inhibits NM IIA assembly via direct interaction with NMHC IIA and reduces cell motility

Biochemical and Biophysical Research Communications

Volumn 428, Issue 1, 2012, Pages 173-178

  Hosono, Yasuyuki ^a   Usukura, Jiro ^b   Yamaguchi, Tomoya ^a   Yanagisawa, Kiyoshi ^a   Suzuki, Motoshi ^a   Takahashi, Takashi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Lung cancer; Migration; MYBPH; Myosin assembly; Non muscle myosin heavy chain; Non muscle myosin IIA

Indexed keywords

BINDING PROTEIN; BLEBBISTATIN; MYOSIN ADENOSINE TRIPHOSPHATASE; MYOSIN BINDING PROTEIN H; MYOSIN HEAVY CHAIN; NONMUSCLE MYOSIN HEAVY CHAIN IIA; RHO KINASE; RHO KINASE 1; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CELL MOTILITY; CELL SURVIVAL; CONTROLLED STUDY; ELECTRON MICROSCOPY; IMMUNOPRECIPITATION; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION;

ACTOMYOSIN; ADENOCARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CYTOSKELETAL PROTEINS; HUMANS; LUNG NEOPLASMS; MOLECULAR MOTOR PROTEINS; MYOSIN HEAVY CHAINS; NONMUSCLE MYOSIN TYPE IIA; RHO-ASSOCIATED KINASES; RNA, SMALL INTERFERING;

EID: 84868383422     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.10.036     Document Type: Article

References (35)

1. Lauffenburger D.A., Horwitz A.F. Cell migration: a physically integrated molecular process. Cell 1996, 84:359-369.
2. Friedl P., Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 2003, 3:362-374.
3. Hall A. The cytoskeleton and cancer. Cancer Metastasis Rev. 2009, 28:5-14.
4. Conti M.A., Adelstein R.S. Nonmuscle myosin II moves in new directions. J. Cell Sci. 2008, 121:11-18.
5. Vicente-Manzanares M., Ma X., Adelstein R.S., Horwitz A.R. Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat. Rev. Mol. Cell Biol. 2009, 10:778-790.
6. Betapudi V., Licate L.S., Egelhoff T.T. Distinct roles of nonmuscle myosin II isoforms in the regulation of MDA-MB-231 breast cancer cell spreading and migration. Cancer Res. 2006, 66:4725-4733.
7. Huang Y., Arora P., McCulloch C.A., Vogel W.F. The collagen receptor DDR1 regulates cell spreading and motility by associating with myosin IIA. J. Cell Sci. 2009, 122:1637-1646.
8. Medjkane S., Perez-Sanchez C., Gaggioli C., Sahai E., Treisman R. Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis. Nat. Cell. Biol. 2009, 11:257-268.
9. Etienne-Manneville S., Hall A. Rho GTPases in cell biology. Nature 2002, 420:629-635.
10. Riento K., Ridley A.J. Rocks: multifunctional kinases in cell behaviour. Nat. Rev. Mol. Cell Biol. 2003, 4:446-456.
11. Itoh K., Yoshioka K., Akedo H., Uehata M., Ishizaki T., Narumiya S. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat. Med. 1999, 5:221-225.
12. Sahai E., Marshall C.J. ROCK and Dia have opposing effects on adherens junctions downstream of Rho. Nat. Cell Biol. 2002, 4:408-415.
13. Wilkinson S., Paterson H.F., Marshall C.J. Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion. Nat. Cell Biol. 2005, 7:255-261.
14. Wong C.C., Wong C.M., Ko F.C., Chan L.K., Ching Y.P., Yam J.W., Ng I.O. Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma. PLoS One 2008, 3:e2779.
15. Dulyaninova N.G., Malashkevich V.N., Almo S.C., Bresnick A.R. Regulation of myosin-IIA assembly and Mts1 binding by heavy chain phosphorylation. Biochemistry 2005, 44:6867-6876.
16. Li Z.H., Bresnick A.R. The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA. Cancer Res. 2006, 66:5173-5180.
17. Kimura S., Hara Y., Pineau T., Fernandez-Salguero P., Fox C.H., Ward J.M., Gonzalez F.J. The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev. 1996, 10:60-69.
18. Yatabe Y., Mitsudomi T., Takahashi T. TTF-1 expression in pulmonary adenocarcinomas. Am. J. Surg. Pathol. 2002, 26:767-773.
19. Takeuchi T., Tomida S., Yatabe Y., Kosaka T., Osada H., Yanagisawa K., Mitsudomi T., Takahashi T. Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J. Clin. Oncol. 2006, 24:1679-1688.
20. Tanaka H., Yanagisawa K., Shinjo K., Taguchi A., Maeno K., Tomida S., Shimada Y., Osada H., Kosaka T., Matsubara H., Mitsudomi T., Sekido Y., Tanimoto M., Yatabe Y., Takahashi T. Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1. Cancer Res. 2007, 67:6007-6011.
21. Kendall J., Liu Q., Bakleh A., Krasnitz A., Nguyen K.C., Lakshmi B., Gerald W.L., Powers S., Mu D. Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc. Natl. Acad. Sci. USA 2007, 104:16663-16668.
22. Weir B.A., Woo M.S., Getz G., Perner S., Ding L., Beroukhim R., Lin W.M., Province M.A., Kraja A., Johnson L.A., Shah K., Sato M., Thomas R.K., Barletta J.A., Borecki I.B., Broderick S., Chang A.C., Chiang D.Y., Chirieac L.R., Cho J., Fujii Y., Gazdar A.F., Giordano T., Greulich H., Hanna M., Johnson B.E., Kris M.G., Lash A., Lin L., Lindeman N., Mardis E.R., McPherson J.D., Minna J.D., Morgan M.B., Nadel M., Orringer M.B., Osborne J.R., Ozenberger B., Ramos A.H., Robinson J., Roth J.A., Rusch V., Sasaki H., Shepherd F., Sougnez C., Spitz M.R., Tsao M.S., Twomey D., Verhaak R.G., Weinstock G.M., Wheeler D.A., Winckler W., Yoshizawa A., Yu S., Zakowski M.F., Zhang Q., Beer D.G., Wistuba, Watson M.A., Garraway L.A., Ladanyi M., Travis W.D., Pao W., Rubin M.A., Gabriel S.B., Gibbs R.A., Varmus H.E., Wilson R.K., Lander E.S., Meyerson M. Characterizing the cancer genome in lung adenocarcinoma. Nature 2007, 450:893-898.
23. Kwei K.A., Kim Y.H., Girard L., Kao J., Pacyna-Gengelbach M., Salari K., Lee J., Choi Y.L., Sato M., Wang P., Hernandez-Boussard T., Gazdar A.F., Petersen I., Minna J.D., Pollack J.R. Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene 2008, 27:3635-3640.
24. Yamaguchi T., Yanagisawa K., Sugiyama R., Hosono Y., Shimada Y., Arima C., Kato S., Tomida S., Suzuki M., Osada H., Takahashi T. NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma. Cancer Cell 2012, 21:348-361.
25. Anagnostou V.K., Syrigos K.N., Bepler G., Homer R.J., Rimm D.L. Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma. J. Clin. Oncol. 2009, 27:271-278.
26. Hosono Y., Yamaguchi T., Mizutani E., Yanagisawa K., Arima C., Tomida S., Shimada Y., Hiraoka M., Kato S., Yokoi K., Suzuki M., Takahashi T. MYBPH, a transcriptional target of TTF-1, inhibits ROCK1, and reduces cell motility and metastasis. EMBO J. 2012, 31:481-493.
27. Straight A.F., Cheung A., Limouze J., Chen I., Westwood N.J., Sellers J.R., Mitchison T.J. Dissecting temporal and spatial control of cytokinesis with a myosin II inhibitor. Science 2003, 299:1743-1747.
28. Cramer L.P., Mitchison T.J. Myosin is involved in postmitotic cell spreading. J. Cell Biol. 1995, 131:179-189.
29. Flashman E., Redwood C., Moolman-Smook J., Watkins H. Cardiac myosin binding protein C: its role in physiology and disease. Circ. Res. 2004, 94:1279-1289.
30. Gaggioli C., Hooper S., Hidalgo-Carcedo C., Grosse R., Marshall J.F., Harrington K., Sahai E. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat. Cell Biol. 2007, 9:1392-1400.
31. Hidalgo-Carcedo C., Hooper S., Chaudhry S.I., Williamson P., Harrington K., Leitinger B., Sahai E. Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nat. Cell Biol. 2011, 13:49-58.
32. Trybus K.M., Lowey S. Conformational states of smooth muscle myosin. Effects of light chain phosphorylation and ionic strength. J. Biol. Chem. 1984, 259:8564-8571.
33. Kim E.J., Helfman D.M. Characterization of the metastasis-associated protein, S100A4. Roles of calcium binding and dimerization in cellular localization and interaction with myosin. J. Biol. Chem. 2003, 278:30063-30073.
34. Franke J.D., Dong F., Rickoll W.L., Kelley M.J., Kiehart D.P. Rod mutations associated with MYH9-related disorders disrupt nonmuscle myosin-IIA assembly. Blood 2005, 105:161-169.
35. Zhang Y., Conti M.A., Malide D., Dong F., Wang A., Shmist Y.A., Liu C., Zerfas P., Daniels M.P., Chan C.C., Kozin E., Kachar B., Kelley M.J., Kopp J.B., Adelstein R.S. Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A. Blood 2012, 119:238-250.